Quintiles Information Library Feed

Quintiles Launches New Capabilities to Enable Biopharma Success in Asia

Thu, 09 Feb 2012 10:35:10 -0500

February 9, 2012 – Quintiles launched two unique services that will help increase the probability of success in developing and commercializing new medications in Asia.

Oncology Experience

Tue, 07 Feb 2012 15:43:58 -0500

Quintiles acquires Outcome to offer full spectrum of inventional and observational research. Together, we offer the expertise and experience in real-world and late phase research Download the PDF

Turkey Oncology Capabilities

Mon, 06 Feb 2012 16:00:00 -0500

Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment. Download the PDF

India Central Laboratory Services

Mon, 06 Feb 2012 15:45:17 -0500

Quintiles offers a local presence in India alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in India, elsewhere in Asia or around the globe. Download the PDF

Fact Sheet Brand Management

Mon, 06 Feb 2012 13:05:02 -0500

Fact Sheet Brand Management Download the PDF

Middle East Oncology capabilities

Mon, 06 Feb 2012 10:51:54 -0500

Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. Download the PDF

South Africa Central Laboratory Services

Mon, 06 Feb 2012 10:37:14 -0500

Quintiles offers a local presence in Africa alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in Africa or around the globe. Download the PDF

DIA China

Fri, 03 Feb 2012 11:56:04 -0500

Quintiles will have a presence

FDA News Annual Risk Management and Drug Safety Summit

Fri, 03 Feb 2012 11:52:18 -0500

Outcome will have a presence

International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Fri, 03 Feb 2012 11:44:53 -0500

Outcome will have an exhibit presence

Health Technology Assessment International Conference

Fri, 03 Feb 2012 11:39:58 -0500

Outcome will have a presence

ISPE Mid-Year Symposium

Fri, 03 Feb 2012 11:29:27 -0500

Outcome will have a presence

Fact Sheet

Fri, 03 Feb 2012 11:20:38 -0500

Vacancy Management Download the PDF

World Drug Safety Congress Americas

Fri, 03 Feb 2012 11:15:41 -0500

Outcome will have a presence

CBI Real World Data Analytics and Outcomes

Fri, 03 Feb 2012 11:11:59 -0500

Outcome will have a presence

Event CBI Drug Safety Forum

Fri, 03 Feb 2012 10:57:13 -0500

Outcome will have a presence

2st Annual Partnerships in Clinical Trials

Fri, 03 Feb 2012 10:52:50 -0500

Outcome will have a presence

CBI 8th Annual Summit on Late Phase Research

Fri, 03 Feb 2012 10:43:58 -0500

Outcome will have a presence and speaking sponsorship

HIMSS

Fri, 03 Feb 2012 10:38:09 -0500

Outcome will be Participating in the Interoperability Showcase

SCOPE Summit Managing Post Marketing

Fri, 03 Feb 2012 10:17:19 -0500

Outcome will have a presence

DIA Europe 2012

Fri, 03 Feb 2012 09:54:56 -0500

We will have a co-branded Outcome-Quintiles exhibit

Reinventing Biopharma

Wed, 01 Feb 2012 17:07:14 -0500

The biopharmaceutical industry today is facing a multifaceted “value challenge.” Download the PDF

Expected Growth of Industry-Sponsored Clinical Trials in the Middle East Benchmarked on other Global Regions

Wed, 01 Feb 2012 06:01:22 -0500

The evolving business model in the biopharmaceutical industry depends on increased productivity in clinical trials. This demands lower-cost, faster and more effective clinical trial processes. Download the PDF

Pharmaceutical Executive: The Power of Observation

Mon, 30 Jan 2012 18:06:15 -0500

Observational studies present a compelling real-world corollary to the classic randomized clinical trial. Download this article to learn how you can build your evidence portfolio. Download the PDF

Registries for Evaluating Patient Outcomes: A User's Guide

Mon, 30 Jan 2012 17:40:39 -0500

Outcome leads the development of best practices for designing and implementing patient registries for real-world observational research. Download the Agency for Healthcare Research & Quality (AHRQ) 2nd edition of Registries for Evaluating Patient Outcomes. Download the PDF

Demonstrating Value in Oncology - Accelerating Patient Recruitment

Thu, 26 Jan 2012 11:40:33 -0500

Presentation at the CBI Oncology Commercialization Strategies Summit by Dr. Stewart Rosen on Clinical Trial Educators in Oncology

Demonstrating Value in Oncology - Thinking Outside the "Sales" Box

Thu, 26 Jan 2012 11:34:26 -0500

Presentation at the CBI Oncology Commercialization Strategies Summit by Susie Newton on Clinical Educators in Oncology

The Power of Observation

Thu, 26 Jan 2012 07:33:26 -0500

As the name implies, in observational studies one 'observes.' The choice of therapy is determined by the patient and her physician rather than protocol, and, Download the PDF

Making Observational Studies Count

Thu, 26 Jan 2012 07:28:27 -0500

There is substantial interest in using observational epidemiologic research in combination with randomized clinical trials (RCTs) and meta-analyses to support decisionmaking by regulators, payers, and Download the PDF

Patient Registries for Understanding the Natural History of Diseases

Thu, 26 Jan 2012 07:20:15 -0500

Understanding the natural history of a disease - its characteristics. management. and outcomes with or without treatment - is critical for developing new therapies. identifying Download the PDF

GRACE Principles: Recognizing High-Quality Observational Studies of Comparative Effectiveness

Thu, 26 Jan 2012 07:15:05 -0500

Comparative effectiveness (CE) has been defined as “the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, Download the PDF

DIA Data Management Japan

Fri, 20 Jan 2012 16:55:52 -0500

Quintiles will have an exhibit

Quintiles Forms New Biomarker Research and Development Company

Wed, 18 Jan 2012 06:00:00 -0500

January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

Cardiac Safety Solutions

Tue, 17 Jan 2012 16:07:09 -0500

Learn how you can proactively assess and manage cardiac safety issues for your entire product development process with the help of our cardiovascular experts and core ECG laboratory providing validated methodology, sophisticated technology and reliable data. Download the PDF

Quintiles Launches Innovative Center of Excellence in Dalian, China

Tue, 17 Jan 2012 13:22:07 -0500

January 17, 2012 – Quintiles is opening a business process outsourcing (BPO) and project management center of excellence with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets.

Quintiles Infosario Clinical Trial Management System Fact Sheet

Tue, 17 Jan 2012 08:59:19 -0500

A fully hosted, global Clinical Trial Management System(CTMS) that provides scalable functionality across multiple business processes. A key component of our Systems as a Service offering, the Quintiles Infosario CTMS provides a centralized location for capturing, viewing, and sharing clinical trial data—from site identification to study closeout. Download the PDF

The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

Mon, 16 Jan 2012 12:00:00 -0500

This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies.

ISPOR Europe 2012

Thu, 12 Jan 2012 11:50:04 -0500

Quintiles will have an exhibit

SCDM 2012

Thu, 12 Jan 2012 11:40:37 -0500

Quintiles will have an exhibit

ISPOR US 2012

Thu, 12 Jan 2012 11:36:23 -0500

Quintiles will have an exhibit

DIA US 2012

Thu, 12 Jan 2012 11:06:15 -0500

Quintiles will have an exhibit

Using Real-time Data to Drive Better Decisions, Faster

Thu, 12 Jan 2012 09:11:45 -0500

This article examines the advantages afforded by access to real-time data during the course of a clinical trial.

ASCO 2012

Wed, 11 Jan 2012 17:33:31 -0500

Quintiles will have an exhibit

12th Annual NICE Conference 2012

Wed, 11 Jan 2012 16:26:20 -0500

Quintiles is a sponsor and will have an exhibit

ISMPP 2012

Wed, 11 Jan 2012 15:56:40 -0500

Quintiles will have an exhibit

BioPharma Asia 2012

Wed, 11 Jan 2012 15:45:52 -0500

Quintiles is a Diamond Sponsor

ASCPT 2012

Wed, 11 Jan 2012 15:39:33 -0500

Quintiles will have an exhibit

CBI Oncology Commercialization Strategies

Wed, 11 Jan 2012 15:30:17 -0500

Quintiles will be leading a workshop session on Day 1, "Demonstrating Value in Oncology, Thinking Outside the Box" and will have an exhibit presence.

Success in Oncology

Wed, 11 Jan 2012 14:43:53 -0500

Quintiles understands stakeholder expectations so you can integrate commercial insights into the development process.

Accelerate Success in Oncology

Wed, 11 Jan 2012 14:25:44 -0500

Quintiles has built strong relationships with local stakeholders to help determine what each is looking for before your clinical studies even begin.

Accelerate Success in Oncology

Wed, 11 Jan 2012 14:07:09 -0500

Quintiles can identify failures faster and prove how your drug will benefit patients.

Accelerate Success in Oncology

Wed, 11 Jan 2012 10:58:01 -0500

Quintiles is the ally that can give your oncology product the best chance to succeed.

FSPs: Ranging from Tactical to Strategic Models

Wed, 04 Jan 2012 10:57:09 -0500

Biopharma companies can choose from a range of outsourcing models as they seek to respond effectively to the ever-changing conditions in the New Health. Download the PDF

Mediguard's 2.5 Million-Strong Patient Community Offers Safe Home for Former Google Health Users

Wed, 04 Jan 2012 09:49:14 -0500

January 4, 2012 - With the ringing in of the new year, patients and family members of the now bygone Google Health can still find a well established, thriving and successful online option for managing personal healthcare information in Quintiles’ MediGuard.org service.

Quintiles Forms Digital Patient Unit

Tue, 03 Jan 2012 11:54:41 -0500

January 3, 2012 - Quintiles today announced the formation of its new Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage with patients.

Clinical Experience Map

Fri, 30 Dec 2011 10:46:03 -0500

Quintiles has a reputation for industry-leading clinical trials experience. And now, that experience is demonstrated with a new tool and just a few mouse clicks.

Quintiles Infosario Lifecycle Safety System Fact Sheet

Wed, 21 Dec 2011 11:14:22 -0500

A comprehensive, cloud-based safety management system that increases customers agility and maximizes cost efficiency. A system designed to manage all safety activities across all programs, Download the PDF

Optimising Patient-Centric Services

Mon, 19 Dec 2011 12:23:14 -0500

The cost of avoidable hospitalisations and disease progression in the United States has reached the unprecedented level of some $290bn per year; in turn these Download the PDF

Regulatory Implications of Technology Platforms for Patient-Centric Services

Mon, 19 Dec 2011 12:14:28 -0500

The rise in healthcare costs has outpaced Gross Domestic Product (GDP) growth since the 1970s. Contributing factors are avoidable hospitalizations and disease progression that add Download the PDF

Why Do I Need Regulatory Affairs Certification (RAC)?

Mon, 19 Dec 2011 12:07:38 -0500

Regulatory Affairs Certification (RAC) is the badge that proves the person carrying it has done the legwork to speak authoritatively in matters that are vital Download the PDF

Press Release Charity 2011

Tue, 13 Dec 2011 11:53:48 -0500

QUINTILES COMMERCIAL GERMANY SUPPORTS INITIATIVE THAT HELPS CHILDREN WITH CANCER AND THEIR FAMILIES FOR 6TH TIME IN A ROW MANNHEIM, 12 DECEMBER 2011: For the Download the PDF

Pressemeldung Charity 2011

Tue, 13 Dec 2011 11:36:00 -0500

QUINTILES COMMERCIAL GERMANY UNTERSTÜTZT ZUM 6. MAL DIE AKTION FÜR KREBSKRANKE KINDER - ORTSVERBAND MANNHEIM DER DEUTSCHEN LEUKÄMIE-FORSCHUNGS-HILFE E.V. MANNHEIM, 12. DEZEMBER 2011: Auch dieses Download the PDF

Intarcia and Quintiles Finalize Innovative Alliance

Tue, 13 Dec 2011 07:43:17 -0500

December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

Quintiles Launches China CRO, Kun Tuo

Tue, 13 Dec 2011 07:01:52 -0500

December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

Harish Dave Discusses ASH 2011

Thu, 08 Dec 2011 14:16:12 -0500

Harish Dave discusses the American Society of Hematology annual meeting.

Sustainable Compliance Begins with a Strong Foundation

Thu, 08 Dec 2011 13:49:28 -0500

The urgency of a problem often entices people to quickly focus on finding a solution and repairing the problem in order to immediately remedy the situation. Download the PDF

The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

Tue, 06 Dec 2011 15:08:43 -0500

This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. Download the PDF

Strategic Alliances

Mon, 05 Dec 2011 15:24:16 -0500

Strategic alliances with specialized external partners allow companies to increase agility and the efficiency of processes, variablize resources and raise the number of promising drug candidates in their pipeline. Download the PDF

Lifecycle Modeling & Simulation

Fri, 02 Dec 2011 13:03:41 -0500

Dennis Gillings, CBE, Quintiles Chairman & Chief Executive Officer, explores a simulation-driven future which he believes is a new frontier for healthcare. Download the PDF

Quintiles Expands World's Largest Cap-Accredited Lab Network

Thu, 01 Dec 2011 08:00:00 -0500

December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles announced the opening of a new, expanded central lab in Centurion, South Africa.

Quintiles and Prodia Partner to Provide Central Lab Testing Solution in Indonesia

Wed, 30 Nov 2011 02:00:00 -0500

November 30, 2011 – Quintiles announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia.

Quintiles Named 2011 Frost & Sullivan Asia Pacific CRO of the Year

Tue, 29 Nov 2011 16:40:33 -0500

November 29, 2011 – For the fourth time in six years, Quintiles has been named Asia Pacific Contract Research Organization of the Year by Frost & Sullivan.

Valérie Hermans

Sun, 27 Nov 2011 19:31:49 -0500

Est-ce que votre formation correspond à votre emploi actuel? En 1999, lorsque j’ai terminé mon Master en Psychologie Clinique, a priori, rien ne me

Valérie Hermans

Sun, 27 Nov 2011 19:31:49 -0500

Est-ce que votre formation correspond à votre emploi actuel? En 1999, lorsque j’ai terminé mon Master en Psychologie Clinique, a priori, rien ne me

Valérie Hermans

Sun, 27 Nov 2011 19:31:49 -0500

Est-ce que votre formation correspond à votre emploi actuel? En 1999, lorsque j’ai terminé mon Master en Psychologie Clinique, a priori, rien ne me

Understanding the Complexity of HTA Networks

Sun, 27 Nov 2011 15:07:38 -0500

As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. Download the PDF

Tomorrow's Vision. Today's Reality.

Wed, 23 Nov 2011 10:14:30 -0500

The growing impact of real-world and late phase (Phase IIIB/IV) research. Download the PDF

Quintiles Commercial Solutions

Mon, 21 Nov 2011 10:06:16 -0500

Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. Download the PDF

Whitepaper Using Real Time Data to Drive Better Decisions, Faster

Mon, 21 Nov 2011 08:51:08 -0500

Using Real-Time Data to Drive Better Decisions, Faster Download the PDF

Whitepaper

Fri, 18 Nov 2011 15:10:52 -0500

A Blueprint for Clinical/Commercial Convergence: Constructing a New Development Model with Market Access Insights Download the PDF

Re-ignite Product Development and Sales with Data Insights: Fueling Innovation Fact Sheet

Thu, 17 Nov 2011 12:54:17 -0500

What Will Drive Biopharma’s Future? The long-dreaded crisis is staring us all in the face: What will take the place of expiring blockbusters with few prospects in hand? Spending on R&D more than doubled after 2002, but the output doesn’t match the investment. The number of new molecular entities has remained a disappointment, averaging only around 20 per year in the US. The big question is how can drug developers carve out a strategic path to innovation? Download the PDF

Market Intelligence - When There's No Room for Error Fact Sheet

Thu, 17 Nov 2011 12:37:51 -0500

In the world of biopharmaceutical development, market researchers are in the hot seat. Crucial decisions hinge on research results more than ever, and each decision must be made even faster to have real impact. Download the PDF

Leveraging Compliance for Sustainable Business Advantage

Wed, 16 Nov 2011 15:57:34 -0500

Article from Update Magazine, a publication of FDLI. “Leveraging Compliance for Sustainable Business Advantage” by Robert A. Rhoades, VP, Quality & Compliance Consulting Download the PDF

Quintiles Sells Minority Interest in Invida

Tue, 15 Nov 2011 16:31:22 -0500

November 15, 2011 – Quintiles has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based Menarini Group, which is acquiring Invida in its entirety.

Pressemeldung

Tue, 15 Nov 2011 14:25:52 -0500

QUINTILES, EIN BESTER MULTINATIONALER ARBEITGEBER im ersten globalen Ranking des Great Place to Work® Instituts Download the PDF

Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Benefit Assessment

Thu, 10 Nov 2011 14:39:56 -0500

Concerns about safety, value, and outcomes are driving demand for more robust evidence about biopharmaceuticals and other medical interventions. Download the PDF

Franchise Influence and Leverage Mapping

Thu, 10 Nov 2011 12:43:05 -0500

In this industry it’s not just whom you know, but who knows you and how far their sphere of influence reaches. Download the PDF

Multi-Channel Strategy

Wed, 09 Nov 2011 11:32:16 -0500

Rethinking the Real Points of Power Today, pharmaceutical and biotech companies relying on a conventional communication strategy aimed squarely and exclusively at physicians find themselves Download the PDF

Quintiles Completes Acquisition of Advion BioServices

Mon, 07 Nov 2011 06:00:00 -0500

November 7, 2011 – Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.

Quintiles Receives Accolades for Connecting Patients to Clinical Research

Thu, 03 Nov 2011 09:54:43 -0500

November 3, 2011 – Quintiles’ digital efforts to bridge the gaps between clinical research, patients and clinical trial participants have been recognized in the form of two International Davey Awards and a Web Health Award this week.

Presentation on Impacting Patient Adherence

Mon, 31 Oct 2011 16:05:16 -0500

Effective learning and the positive effect on patients -crucial steps and successful tools Diabetes and MS case studies presented at the US Patient Adherence Summit

Timely Insight – Protocol Deviation Use Case

Fri, 28 Oct 2011 11:31:53 -0500

Quintiles Infosario helps to rapidly identify a protocol deviation pattern and immediately drill-down to investigate. This is a simple example of how having the right

Early Signal Detection

Fri, 28 Oct 2011 11:30:17 -0500

Quintiles Infosario helps users spot trends and proactively detect soft signals early on—before they become big problems.

Smarter IT Systems

Fri, 28 Oct 2011 11:28:31 -0500

Quintiles Infosario Systems as a Service products help avoid fixed IT investment and maintenance costs while gaining operational efficiencies. So you can focus on your

Data Factory – From Data to Integration

Fri, 28 Oct 2011 11:21:49 -0500

The Quintiles Infosario Reporting & Analytics platform continuously gathers subject, operational and support data across multiple source systems. Then it integrates and harmonizes the data

Data Innovation Overview

Fri, 28 Oct 2011 11:21:48 -0500

Quintiles Infosario utilizes four foundational services: Reporting & Analytics, Data-driven Process, Data Archival & Warehousing, and Systems as a Service to transform information into actionable

Improved Safety – Short Use Case

Fri, 28 Oct 2011 11:20:13 -0500

Quintiles Infosario provides immediate access to data, which allows users to drill down and identify at-risk patient profiles and quickly address concerns affecting patient well-being.

Immediate Integrated Data Access

Fri, 28 Oct 2011 11:18:24 -0500

Quintiles Infosario helps enable improved medical surveillance by providing near-immediate access to comprehensive integrated clinical data, all in one place. So users can quickly and

Quintiles Recognized as a Top Multinational Employer

Fri, 28 Oct 2011 08:47:39 -0500

October 28, 2011 – Quintiles is ranked 25th in the inaugural World’s Best Multinational Workplaces list from the Great Place to Work® Institute.

Quintiles Agrees to Acquire Premier GLP Bioanalytics Laboratory

Wed, 26 Oct 2011 09:03:53 -0500

October 26, 2011 – To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles signed of a definitive agreement to acquire Advion BioServices.

Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.

Wed, 19 Oct 2011 12:30:00 -0500

October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).

Quintiles Acquires VCG & Associates and VCG Bio

Wed, 19 Oct 2011 08:30:00 -0500

October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

Health Management Solutions Brochure

Tue, 18 Oct 2011 16:00:41 -0500

Health Management Solutions Brochure Download the PDF

Quintiles Consolidates EU Business with Headquarters in UK

Wed, 12 Oct 2011 00:00:00 -0500

October 12, 2011 – Quintiles, the only fully integrated bio pharmaceutical services provider offering clinical, commercial, consulting and capital solutions worldwide, officially opened its new European Headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

Podcast: Global Biosimilars Outlook

Tue, 11 Oct 2011 11:50:16 -0500

Dr. Amar Kureishi, Regional Chief Medical Officer, Asia-Pacific, Quintiles, discusses the main drivers behind the growth of biosimilars, and offers suggestions for biopharmaceutical companies looking to enter the space.

Broschüre Innovation Imperative in Biopharma

Fri, 07 Oct 2011 09:22:54 -0500

The Innovation Imperative in Biopharma Download the PDF

Press Release Top credit rating

Thu, 06 Oct 2011 15:29:06 -0500

Top Credit Rating for Quintiles Commercial Germany Hoppenstedt, one of the leading credit and commercial rating agencies awarded Quintiles Commercial Germany a top credit rating Download the PDF

Pressemeldung

Thu, 06 Oct 2011 14:52:25 -0500

Top Bonitätsrating von Hoppenstedt für Quintiles Commercial Germany Mannheim, 4. Oktober 2011 Hoppenstedt, einer der führenden Anbieter von Bonitäts- und Wirtschaftsinformationen, hat Quintiles Commercial Germany Download the PDF

Broschüre

Thu, 06 Oct 2011 11:49:19 -0500

The New Health Report Download the PDF

Clinical Evaluation Medical Devices

Thu, 06 Oct 2011 09:17:44 -0500

A Clinical Evaluation Report (CER) is a living document required for all classes of new and existing products within the EU, detailing the clinical evaluation of a product throughout its life-cycle. Additional focus has been placed on clinical evaluations since changes in the Medical Devices Directive [“MDD”]1 have come into force in March 2010. A renewed focus by Notified Bodies on clinical evaluations, against the updated legislation, has led to a number of audit observations against manufacturers with regard to CER’s containing insufficient clinical data, or manufacturers not holding product CER’s. Download the PDF

Quintiles Names New Global Head of Clinical & Data Operations

Thu, 06 Oct 2011 06:00:00 -0500

October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

Creating Metadata-Driven Program Logic

Tue, 04 Oct 2011 14:25:45 -0500

This paper presents a solution in which a DATA step is used to access CTC grading logic metadata and the CALL EXECUTE routine is used to place the associated SAS® statements in the SAS command stack for execution after the DATA step has finished. This process creates a virtual DATA step that will assign the CTC grades to each observation in the laboratory results data set. Download the PDF

Energizing Enrollment

Tue, 04 Oct 2011 14:22:38 -0500

The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. Download the PDF

Model-Based Drug Development

Tue, 04 Oct 2011 12:52:59 -0500

Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns. Download the PDF

Quintiles Addresses Key Considerations for Successful Biosimilar Development

Fri, 30 Sep 2011 14:53:19 -0500

September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

Fuzzy Merges - A Guide to Joining Datasets with Non-Exact Keys Using SAS Proc SQL

Fri, 30 Sep 2011 13:17:57 -0500

Robert W. Graebner put forth a paper discussing "Fuzzy Merges - A Guide to Joining Datasets with Non-Exact Keys Using SAS Proc SQL" at the Download the PDF

Podcast: Real-time Data and Patient Safety

Fri, 30 Sep 2011 06:02:01 -0500

Andrew Garrett, Global Head of Biostatistics, Medical Writing and Regulatory Affairs for Quintiles, discusses how real-time collection of clinical research data can accelerate development timelines and better ensure patient safety.

Podcast: Strategic Considerations for Biosimilar Development & Commercialization

Fri, 30 Sep 2011 05:11:50 -0500

Deepa Dahal, Principal Consultant, Consulting at Quintiles, and Dr. Nigel Rulewski, Vice President of Global Strategic Drug Development, emphasize an integrated approach to biosimilar development and commercialization.

An Integrated Approach to Biosimilar Development & Commercialization

Thu, 29 Sep 2011 00:00:00 -0500

As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. Download the PDF

Partnering is Key to Maximizing Rewards in Emerging Markets

Tue, 27 Sep 2011 06:00:00 -0500

September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

Web-based ePRO Tools and Post-Marketing Studies

Mon, 26 Sep 2011 13:07:04 -0500

Eric Gemmen discusses "Web-based ePRO Tools and Post-Marketing Studies" with Scott Dixon from Oracle Health Sciences at the Society for Clinical Data Management, September 11-14, Download the PDF

The Use of Textbook Reference Ranges in Oncology Studies

Thu, 22 Sep 2011 18:12:07 -0500

Joyce Stevens discusses "The Use of Textbook Reference Ranges in Oncology Studies" at the Society for Clinical Data Management, September 11-14, 2011 in Baltimore, MD, Download the PDF

Blurring the Line Between Clinical and Data Monitoring

Thu, 22 Sep 2011 18:05:55 -0500

Amy Kissam discusses "Blurring the Line Between Clinical and Data Monitoring" at the Society for Clinical Data Management, September 11-14, 2011 in Baltimore, MD, US. Download the PDF

Ensuring Data Quality in an EDC Study: When Traditional QC No Longer Applies

Thu, 22 Sep 2011 18:00:15 -0500

Ellen Morrow discusses "Ensuring Data Quality in an EDC Study: When Traditional QC No Longer Applies" at the Society for Clinical Data Management, September 11-14, Download the PDF

Data Surveillance - A Prerequisite for Adaptive Clinical Trial Execution

Thu, 22 Sep 2011 17:18:47 -0500

Thomas Grundstrom discusses "Data Surveillance - A Prerequisite for Adaptive Clinical Trial Execution" at the Society for Clinical Data Management, September 11-14, 2011 in Baltimore, Download the PDF

Off-Shoring - From Tactical to Strategic

Thu, 22 Sep 2011 17:13:31 -0500

Richard Cesarski and Michael Fiola discuss "Off-Shoring - From Tactical to Strategic" at the Society for Clinical Data Management, September 11-14, 2011 in Baltimore, MD, Download the PDF

Beyond Tables and P-values: Enhancing the Role of the Clinical Trial Team Statistician

Thu, 22 Sep 2011 17:04:33 -0500

Sonia Davis discusses "Beyond Tables and P-values: Enhancing the Role of the Clinical Trial Team Statistician" at the FDA/Industry Statistics Workshop, on September 20, 2011. Download the PDF

Development of CDISC Tuberculosis Data Standards

Thu, 22 Sep 2011 16:51:10 -0500

Michael Fiola discusses "Development of CDISC Tuberculosis Data Standards" at the Society for Clinical Data Management, September 11-14, 2011 in Baltimore, MD, US. Download the PDF

Multi-Channel Sales Solutions - PM Europe Article

Thu, 22 Sep 2011 09:43:58 -0500

Current challenges like diminishing product pipelines, tougher regulatory regulations and promotional standards lead to the need for pharma to re-think their current sales model. Download the PDF

Quintiles Names Charles Williams to Serve as Worldwide Controller

Thu, 22 Sep 2011 07:57:46 -0500

September 22, 2011 - Quintiles has named Charles Williams to serve as its worldwide controller within the company’s finance organization. A 34-year veteran of corporate finance and accounting, Williams reports directly to Chief Financial Officer Kevin Gordon.

Improving Adherence

Wed, 21 Sep 2011 15:15:16 -0500

Diabetes management education is especially critical to adherence and persistency among these newly diagnosed patients. But with health care professionals (HCPs) and long-term caregivers (LTCs) facing severely compressed schedules, there is limited time during appointments for these critical discussions. Download the PDF

The Value of Dual Perspectives

Wed, 21 Sep 2011 00:19:59 -0500

When one of the world’s largest pharmaceutical companies needed insight into how key components of their tactical sales approach were actually implemented in the field, they looked to Quintiles Market Intelligence. Download the PDF

Improving Clinical Decision Making

Wed, 21 Sep 2011 00:18:33 -0500

With increased movement of pharmaceutical clinical studies to outsourced providers, a new paradigm of work was needed for clinical development between a Sponsor and a CRO. To meet this industry need, Quintiles partnered with a world class pharmaceutical company to build a new model for clinical trial planning and design. As part of this joint venture, Consulting at Quintiles is leveraging best practices previously implemented with other companies to highlight effective convergence of clinical and consulting expertise. Download the PDF

Clinical Educator Programs

Mon, 19 Sep 2011 14:31:54 -0500

Today’s pharma landscape is fast-paced and constantly changing. As practitioners’ schedules become more compressed, there is little time to discuss new products or complex therapeutics Download the PDF

Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage

Mon, 19 Sep 2011 06:00:00 -0500

September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.

Quintiles Receives ACCME Accreditation With Commendation

Fri, 16 Sep 2011 16:00:39 -0500

As Managing Director, I am pleased to announce that Quintiles Medical Education (QME) has received Accreditation with Commendation as a provider of Continuing Medical Education

Partnering to Maximize Rewards in Pharmerging Markets

Thu, 15 Sep 2011 18:36:17 -0500

In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. Download the PDF

How Informative is Your Segmentation?

Thu, 15 Sep 2011 12:25:09 -0500

Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011. Download the PDF

Quintiles Market Research Expert Honored by American Marketing Association Foundation

Thu, 15 Sep 2011 10:37:48 -0500

September 15, 2011 – Quintiles announced that The American Marketing Association (AMA) Foundation selected an article co-authored by Pieter Sheth-Voss, of Consulting at Quintiles, to receive the 2011 David K. Hardin Award.

Quintiles Recognized as One of The Best Technology Innovators & Industry Leaders by InformationWeek

Wed, 14 Sep 2011 08:50:37 -0500

September 14, 2011 – Quintiles was named 4th in the prestigious InformationWeek 500 technology innovators rankings for its Quintiles INFOSARIO™ platform. The company was also recognized as the industry leader in the biotech and pharmaceutical category.

Polish Pharmaceutical and Healthcare Sector

Fri, 09 Sep 2011 16:43:09 -0500

To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research Download the PDF

Vladimir Misik, Ph.D.

Wed, 07 Sep 2011 10:24:25 -0500

Vladimir, as Senior Regional Director, Middle East, Clinical Operations, is responsible for the clinical development of the Middle East region which includes Egypt, Jordan, Lebanon,

Shifting Sands

Fri, 02 Sep 2011 09:40:47 -0500

As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa. Download the PDF

Quintiles Appoints Global Head of Phase I Division

Wed, 31 Aug 2011 09:00:00 -0500

August 31, 2011 – Quintiles announced that Oren Cohen, M.D., will serve as Senior Vice President and Global Head of its Phase I Clinical Research division, which includes world-class facilities in Overland Park, Kansas (U.S.), London (U.K.) and Hyderabad (India).

Quintiles President of Clinical Development Receives 'Women in Business' Award

Fri, 26 Aug 2011 14:00:00 -0500

August 26, 2011 – Quintiles announced that Paula Brown Stafford, President of Clinical Development, was honored as a recipient of Triangle Business Journal’s Women in Business awards for 2011.

Innovations in Translational Medicine: Using the Clinical Cloud to Improve the Probability of Success

Fri, 26 Aug 2011 13:51:13 -0500

Download the presentation of Innovations in Translational Medicine: Using the Clinical Cloud to Improve the Probability of Success -- A Guide to Drug Discovery and Development presented by John Murphy, Ph.D., Senior Director of Clinical Analytics for Consulting at Quintiles. John made this presentation at Quintiles Executive Vision Forum: Data Driven Innovation in July 2011. Download the PDF

Where are the Cures? How Data Driven Innovation Can Help

Fri, 26 Aug 2011 13:41:34 -0500

Download the presentation of Where Are the Cures?: How Data Driven Innovation Can Help presented by Adam Clark, Ph.D., Director of Scientific and Federal Affairs. Adam made this presentation at Quintiles Executive Vision Forum: Data Driven Innovation in July 2011. The presentation specific initiatives and research models that are helping drive and cultivate innovation, accelerating commercialization and drug development in the biopharma industry. Download the PDF

Empowering More Precise Decision-Making in Healthcare

Fri, 26 Aug 2011 13:34:30 -0500

Download the presentation of Empowering More Precise Decision-making in Healthcare presented by Mark Cziraky, PharmaD., Vice President, Industry Sponsored Research for Healthcore, a Wellpoint Company. Mark made this presentation at Quintiles Executive Vision Forum: Data Driven Innovation in July 2011. The presentation shares some of the paradigms HeathCore sees in the evolving healthcare landscape – in particular, focusing on specific initiatives and ideas that are helping to better integrate practicing physicians into the research process and implement the results at the point of care. Download the PDF

Exploring New Ground for Pharma: Partnering on Innovation

Fri, 26 Aug 2011 13:21:08 -0500

View the presentation of Exploring New Grounds for Pharma: Partnering on Innovation presented by Morten Sogaard, Ph.D., Executive Director and Head of the Biotechnology Unit at Download the PDF

Adam Clark, PhD

Fri, 26 Aug 2011 12:56:53 -0500

Adam Clark, Ph.D. is the Director of Scientific and Federal Affairs at FasterCures. Dr. Clark leads FasterCures programmatic efforts to bolster innovation at the National

Editor’s Commentary

Thu, 25 Aug 2011 09:07:57 -0500

Rick Turner's editor's commentary from the July 2011 issue of the Drug Information Journal. Download the PDF

Editor’s Commentary

Thu, 25 Aug 2011 09:02:36 -0500

Rick Turner's editor's commentary from the May 2011 issue of the Drug Information Journal. Download the PDF

Editor’s Commentary

Thu, 25 Aug 2011 08:52:24 -0500

Rick Turner's editor's commentary from the Drug Information Journal. Download the PDF

Editor’s Commentary

Thu, 25 Aug 2011 08:42:21 -0500

Rick Turner's editor's commentary from the Drug Information Journal. Download the PDF

John J. Doyle, Dr.P.H., M.P.H.

Wed, 24 Aug 2011 10:30:49 -0500

Dr. John Doyle leads the U.S. Managed Markets practice for Quintiles Consulting.

Grace-Marie Turner

Tue, 23 Aug 2011 17:28:08 -0500

Grace-Marie Turner is president of the Galen Institute, a public policy research organization that she founded in 1995 to promote an informed debate over free-market ideas for health reform.

Helen Sherman

Tue, 23 Aug 2011 17:23:44 -0500

Helen Sherman is Chief Pharmacy Officer of Pharmacy Services for RegenceRx.

Edmund Pezalla, M.D., MPH

Tue, 23 Aug 2011 17:19:53 -0500

Edmund Pezalla, M.D., MPH, is Aetna’s National Medical Director for Pharmaceutical Policy and Strategy.

Frank Norman

Tue, 23 Aug 2011 17:18:18 -0500

Frank Norman has over 26 years of experience in strategic business and technology leadership with significant knowledge of the health care & life sciences, insurance, and banking industries.

Peter Kolchinsky, PhD

Tue, 23 Aug 2011 17:11:35 -0500

Dr. Kolchinsky is a co-founder and General Partner of RA Capital Management, which has been investing in healthcare companies since 2002. He is a member

Diane Edquist Dorman

Tue, 23 Aug 2011 17:08:58 -0500

Ms. Dorman is the Vice President for Public Policy for the National Organization for Rare Disorders (NORD).

CHESTER “CHIP” DAVIS, JR., J.D.

Tue, 23 Aug 2011 16:59:16 -0500

Chester “Chip” Davis, Jr. currently serves as Executive Vice President for Advocacy at PhRMA.

The New Health

Tue, 23 Aug 2011 10:07:54 -0500

In 2010, Quintiles advanced the concept of the New Health, our perspective on the fast-morphing biopharma landscape, where the rules are changing on all fronts. Download the PDF

Fact Sheet

Tue, 23 Aug 2011 09:31:47 -0500

Fact Sheet Brand Management Download the PDF

Blind Review of Planned Analyses for Clinical Trials

Wed, 17 Aug 2011 13:55:52 -0500

Lan Liu and John Schollenberger discuss "Blind Review of Planned Analyses for Clinical Trials" at the 2011 Joint Statistical Meetings, July - August 2011 in Download the PDF

Sample Size Estimation For Drug Combination In Fixed Dose Trials

Wed, 17 Aug 2011 13:39:56 -0500

Jie Wang, PhD, discusses "Sample Size Estimation For Drug Combination In Fixed Dose Trials" at the 2011 Joint Statistical Meetings, July - August 2011 in Download the PDF

Artikel im Pharmabarometer

Wed, 17 Aug 2011 09:39:00 -0500

So stark können Mature Products sein - Quintiles Download the PDF

Podcast: Late Phase Research Strategies

Mon, 08 Aug 2011 12:39:38 -0500

Louise Parmenter, Ph.D., Senior Director, Late Phase Strategic Planning for Quintiles, discusses late phase research methods and their implications for drug development.

Quintiles Names Jeffrey Spaeder Chief Medical and Scientific Officer

Wed, 03 Aug 2011 15:08:53 -0500

August 3, 2011 - Quintiles announced the appointment of Jeffrey A. Spaeder, M.D., as its Chief Medical and Scientific Officer, representing the company's position on a wide variety of governance, ethical and scientific issues.

Quintiles, Kadrige Open E-Solutions Operation in the US

Tue, 02 Aug 2011 09:07:36 -0500

August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.

Easing Compliance Burden

Mon, 01 Aug 2011 16:50:33 -0500

In today’s pharmaceutical development environment, regulatory compliance is more important than ever due to increased regulatory oversight from health authorities coupled with growing penalties for Download the PDF

Make Smarter Choices

Fri, 22 Jul 2011 13:42:06 -0500

In your world, every grain of data matters — and every minute counts. To make the most of what you’ve got, turn to Model-Based Drug Development.

Optimizing Type II Diabetes Drug Development

Thu, 21 Jul 2011 10:48:19 -0500

Zoran Antonijevic discusses "Optimizing Type II Diabetes Drug Development" at the DIA 2011 47th Annual Meeting in Chicago, IL, US. Download the PDF

Using Regulatory Guidance to Get Credible Results with Missing Data

Thu, 21 Jul 2011 10:43:31 -0500

Michael O'Kelly discusses "Using Regulatory Guidance to Get Credible Results with Missing Data" at the DIA 2011 47th Annual Meeting in Chicago, IL, US. Download the PDF

Alzheimer’s Drug Development: A Look Into the Future

Wed, 20 Jul 2011 13:51:40 -0500

Amir Kalali MD, discusses the challenges facing Alzheimer's trials today. Download the PDF

Green Park Reading Location Map

Wed, 20 Jul 2011 09:54:04 -0500

Map of the New European Head Office located at Green Park, Reading, Berkshire Download the PDF

Quintiles and the NHS

Tue, 19 Jul 2011 16:18:30 -0500

Let us show you how Quintiles delivers on its promise. Download the PDF

Commercial Brochure

Mon, 18 Jul 2011 13:18:57 -0500

commercial identify, promote and prove treatment value Download the PDF

Methods Matter

Mon, 18 Jul 2011 07:41:22 -0500

As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs. Download the PDF

Fact Sheet High

Fri, 15 Jul 2011 12:40:55 -0500

High Impact Selling Training (HIS) Download the PDF

Economist Intelligence Unit, Quintiles Find Innovation is Vital to Future of Biopharma

Tue, 12 Jul 2011 06:00:00 -0500

July 12, 2011 – A new Economist Intelligence Unit survey sponsored by Quintiles highlights the urgent need for bio pharmaceutical industry innovation.

Reinventing Biopharma

Mon, 11 Jul 2011 11:42:31 -0500

It’s not easy being a life sciences firm today. Companies in the sector have seen rising research and development (R&D) costs, in exchange for flat, or even diminishing, innovation returns. Download the PDF

Quintiles, Queen Mary University Collaborate to Accelerate Clinical Research

Thu, 07 Jul 2011 00:00:00 -0500

July 7, 2011 – Quintiles reached a significant milestone in its prime site program with the official opening of a clinical research facility within Queen Mary, University of London.

Portfolio Evaluation & Selection for Contract Sales

Wed, 06 Jul 2011 11:20:49 -0500

Neil Ferguson - Vice President, Head of US Commercial Sales at Quintiles, presented ways to select the right product portfolio for successful strategic commercial outsourcing.

Clinical Trial Educators

Wed, 06 Jul 2011 10:12:44 -0500

Stewart Rosen discusses the role of Clinical Trial Educators in Enrollment and Retention.

Morten Sogaard, PhD

Tue, 05 Jul 2011 15:34:25 -0500

In close collaboration with Pfizer’s CSOs, External R&D Innovation identifies, evaluates and funds Pfizer’s large R&D collaborations. Morten’s team is responsible for technology and oncology

A Focus on CNS

Fri, 01 Jul 2011 15:20:45 -0500

Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. Download the PDF

Quintiles Helps Biopharma Companies Turn Compliance into a Business Advantage

Wed, 29 Jun 2011 09:30:00 -0500

June 29, 2011 – Elevating compliance to achieve a strategic advantage allows biopharmaceutical companies to respond more rapidly to ever-changing conditions in the New Health, according to a new report from Consulting at Quintiles.

Margaret A. Anderson

Tue, 28 Jun 2011 11:45:19 -0500

Margaret Anderson is executive director of FasterCures/The Center for Accelerating Medical Solutions, an “action tank” working to improve the medical research system – so that

Global Clinical Trials: Effective Implementation and Management

Tue, 28 Jun 2011 10:39:04 -0500

Seventeen Quintiles experts from around the world collaborated to produce these key chapters in “Global Clinical Trials: Effective Implementation and Management.” Download the PDF

Quintiles Infosario - 30 Seconds

Sun, 26 Jun 2011 18:54:33 -0500

Quintiles Infosario™ delivers this and so much more. A comprehensive new suite of services, Quintiles Infosario seamlessly integrates data, systems, processes and expertise to help

Quintiles Infosario

Sun, 26 Jun 2011 17:24:10 -0500

Quintiles Infosario™ delivers this and so much more. A comprehensive new suite of services, Quintiles Infosario seamlessly integrates data, systems, processes and expertise to help

Australia and New Zealand Phase II/III Fact Sheet

Fri, 24 Jun 2011 15:53:36 -0500

Australia and New Zealand fact sheet around Phase II/III trials. Same language. Same technology. Same quality standards. Download the PDF

Off-Season Pediatric Enrollment

Fri, 24 Jun 2011 15:32:02 -0500

This sponsor needed to conduct a pediatric influenza during the off-season months of March - May. Quintiles completed enrollment and database lock ahead of schedule. Download the PDF

Malaria Prevention in Sub-Saharan Africa

Fri, 24 Jun 2011 14:30:30 -0500

This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands Download the PDF

The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

Thu, 23 Jun 2011 14:33:45 -0500

In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. Download the PDF

Digital Pathology Central Laboratory Services Fact Sheet

Thu, 23 Jun 2011 14:23:15 -0500

This fact sheet highlights Quintiles' digital pathology services, covering everything from scanning of slides to review and analysis - giving you a faster, easier way to scan and share this critical research data. Download the PDF

Quintiles Wins Best CRO in Vaccine Excellence Asia Awards 2011

Thu, 23 Jun 2011 12:04:45 -0500

June 23, 2011 – Quintiles, a leading global biopharmaceutical services company, today announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Asia Awards 2011.

Mark J. Cziraky, PharmD

Wed, 22 Jun 2011 11:11:10 -0500

HealthCore co-founder and Vice President, Industry Sponsored Research, Dr. Mark Cziraky, has been extensively involved with clinical, health economic and outcomes research for more than

Quintiles Honored by Computerworld as One of the Best Places to Work in IT

Wed, 22 Jun 2011 11:09:52 -0500

June 22, 2011 - Quintiles has been named to Computerworld magazine’s “100 Best Places to Work in IT” list for a third time.